Yangjian Liu

Title: Profile of Inventor Yangjian Liu: A Pioneer in Pyrrolopyrimidine Compounds

Introduction: Yangjian Liu is a notable inventor based in Beijing, CN. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on pyrrolopyrimidine compounds. His dedication and research have led to the development of a unique compound that shows promise in treating diseases influenced by Janus kinase.

Latest Patents: Yangjian Liu holds a patent for a pyrrolopyrimidine comprising a cyclopentyl substituent. This invention specifically pertains to a compound represented by a designated formula, along with its stereoisomers and pharmaceutically acceptable salts. The patent also details a method for manufacturing this compound, along with its applications in pharmaceutical compositions aimed at treating certain medical conditions related to Janus kinase.

Career Highlights: Throughout his career, Yangjian Liu has worked with esteemed companies in the pharmaceutical industry, including Centaurus Biopharma Co., Ltd. and Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His experiences at these organizations have allowed him to advance his knowledge and expertise in drug development and innovation.

Collaborations: In his professional journey, Yangjian Liu has had the opportunity to collaborate with notable colleagues such as Li Zhu and Chuanyu Zhang. These collaborations have likely fostered a creative and productive environment that spurs further advancements in their shared fields of study.

Conclusion: Yangjian Liu is a distinguished inventor whose work in developing a cyclopentyl substituted pyrrolopyrimidine compound has significant potential in the pharmaceutical world. His contributions not only enhance our understanding of medicinal chemistry but also pave the way for future innovations in treating diseases linked to Janus kinase.